Log In
Print
BCIQ
Print
Print this Print this
 

VN-100

  Manage Alerts
Collapse Summary General Information
Company VentriNova Inc.
DescriptionAdenoviral vector encoding cyclin A2 (CCNA2)
Molecular Target Cyclin A2 (CCNA2)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPreclinical
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat myocardial infarction (MI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today